Letter to Editor: Authors' response to “Respondence of ‘Brain iron deposition and whole-exome sequencing of non-Wilson's disease hypoceruloplasminemia in a family’”

Xu ZX, Zhou YY, Wu R, et al. Brain iron deposition and whole-exome sequencing of non-Wilson’s disease hypoceruloplasminemia in a family. J Neurorestoratol. 2023;11(1):100027. https://doi.org/10.1016/j.jnrt.2022.100027.

Cai HX, Cheng X, Wang XP. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease. Hepatology. 2022;76(4):1046-1057. https://doi.org/10.1002/hep.32484.

Nittis T, Gitlin JD. The copper-iron connection: hereditary aceruloplasminemia. Semin Hematol. 2002;39(4):282-289. https://doi.org/10.1053/shem.2002.35633.

Su DN, Zhang ZJ, Zhang Z, et al. Distinctive pattern of metal deposition in neurologic Wilson disease: insights from 7T susceptibility-weighted imaging. Neurology. 2024;102(12):e209478. https://doi.org/10.1212/WNL.0000000000209478.

Li GY, Wu R, Tong R, et al. Quantitative measurement of metal accumulation in brain of patients with Wilson's disease. Mov Disord. 2020;35(10):1787-1795. https://doi.org/10.1002/mds.28141.

Litwin T, Dusek P, Antos A, et al. Tackling the neurological manifestations in Wilson's disease - currently available treatment options. Expert Rev Neurother. 2023;23(12):1249-1259. https://doi.org/10.1080/14737175.2023.2268841.

Roberts EA, Schilsky ML. Current and emerging issues in Wilson's disease. N Engl J Med. 2023;389(10):922-938. https://doi.org/10.1056/NEJMra1903585.